tirzepatide surpass cvot 🫀 EASD 2025: (SURPASS-CVOT) Dulaglutide head-to-head showdown: ✓ Noninferior for MACE ✓ 16% ↓ all-cause mortality ✓ Superior in A1C & weight loss Tirzepatide confirms its broad cardiometabolic edge. #EASD2025 # Tirzepatide #GLP1 Efficacy and safety of a

El semaglutide es un medicamento usado para tratar la diabetes y se ha popularizado como una forma de perder peso, pero para estar seguros y saber qu inyectamos en nuestro cuerpo, Dr

GLP-1 drugs, which have helped some people curb drug and alcohol use, may unlock a pathway to moderation.

Gala GLP-1 review: we scored it 3.5/5 a competitive option

This paper advances a testable hypothesis: reductions in food noise may shift the balance of activity among DMN, salience, and executive networks in ways that support more adaptive forms of prospection

In Canada, Apo-Semaglutide Injection is indicated for the once-weekly treatment of adults with type 2 #diabetes mellitus to improve glycemic control, in combination with #diet and #exercise